Spatial mapping technique allows researchers to understand tumor architecture

medicalxpress - Tumors contain many different types of cells organized in complex spatial patterns that can influence how the disease progresses. Because of this, it is hard to predict how a tumor will develop and respond to treatment. Researchers at the University of Il…

AI Summary: Advanced spatial mapping techniques revealed how tumor architecture and local microenvironments reorganize — including changes driven by tumor‑linked viruses — altering immune cell positioning and signaling. The work provides a high‑resolution blueprint for understanding treatment resistance and suggests new targets for precision therapies that consider the tumor’s geographic biology, not just its genetics.


Field report: Immune geography dictates therapy response and resistance

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily


On scene: microbes and viruses remap tumor microenvironments

3 months / medicalxpress

3 months / sciencedaily

3 months / oncodaily


On the ground: spatial multi-omics maps tumor architecture

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress


Other: Miscellaneous tumor biology, therapies, biomarkers

3 months / nature

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / nature

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / nature

3 months / oncodaily

3 months / oncodaily

3 months / nature


All Other Stories

3 months / oncodaily

3 months / medicalxpress

3 months / medicalxpress

3 months / medicalxpress

3 months / oncodaily

3 months / oncodaily

3 months / medicalxpress

3 months / oncodaily

3 months / sciencedaily

3 months / oncodaily

3 months / oncodaily





Related Stories


Phages repurpose vaccine immunity to attack cancer cells / 12 days

Mass spectrometry platform could cut drug discovery to hours / 20 days

Engineered CAR‑T cells secreting VEGF‑neutralizing scFvs boost solid‑tumor activity / 4 months

EMERALD‑3 tests tremelimumab/durvalumab combos for embolisation‑eligible HCC / 7 days

Long‑term Botensilimab+Balstilimab data show durable responses in MSS CRC / 13 days

Some tumors kill neighboring healthy cells to fuel growth / 4 wks

Zanidatamab improves PFS over trastuzumab in HER2 GEA / 5 wks

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Nutrition, Medicaid, Diagnostics, Product Recall and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.